{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-23-000147","form_type":"8-K","ticker":"CMMB","cik":"0001534248","company_name":"Chemomab Therapeutics Ltd.","filed_at":"2023-01-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.473541+00:00","generated_at":"2026-06-20T16:32:29.870320+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Chemomab Therapeutics furnishes updated corporate presentation; no specific facts available from filing text","bullets":["Chemomab Therapeutics filed an updated corporate presentation on January 11, 2023.","The presentation is intended for investor and analyst use; no financial results or material events were announced.","No further details from the presentation are included in the filing text provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-23-000147","json":"https://secwatch.observer/filing/0001178913-23-000147.json","markdown":"https://secwatch.observer/filing/0001178913-23-000147.md","text":"https://secwatch.observer/filing/0001178913-23-000147.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323000147/0001178913-23-000147-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534248/000117891323000147/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T16:32:29.870320+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}